Effect of the glucagon-like peptide-1 receptor agonists semaglutide and liraglutide on kidney outcomes in patients with type 2 diabetes: pooled analysis of SUSTAIN 6 and LEADER
Semaglutide replicates these effects, helping individuals consume fewer calories, which can be particularly beneficial for those looking to lose weight as part of a broader aesthetic or health-related goal
We are likely to continue to see clinical trials include treatment of adiposity-related diseases as a component of obesity medication investigations
The adequate management of GI AEs would potentially improve a patients experience while undergoing treatment with GLP-1 RA, preventing discontinuations secondary to GI AEs
This activity is designated for 1.50 AAPA Category 1 CME credits
The name itself may evoke banners and trumpets, but what matters to careful players is the foundation: licensing, banking transparency, and tools that keep you in control